Evidence map›Paper›PMID 40941989›Full record

ArticleMolecules (Basel, Switzerland)2025

Ginsenoside Re Regulates the Insulin/Insulin-like Growth Factor-1 Signaling Pathway and Mediates Lipid Metabolism to Achieve Anti-Aging Effects in

Qi Chen, Xiaolu Chen, Linzhen Chen, Xue Zhang, Zhuo Yang, Juhui Hao, Zhiqiang Ma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qi ChenBeijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Xiaolu ChenBeijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Linzhen ChenBeijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Xue ZhangTraditional Chinese Medicine Processing Technology Inheritance Base of National Administration of Traditional Chinese Medicine, Beijing 102488, China.
Zhuo YangBeijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Juhui HaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Zhiqiang MaBeijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing demographic aging of society is a great challenge to the healthcare sector and raises the socio-economic burden. Therefore, elucidating the mechanisms of aging and developing safe effective anti-aging products to prolong people's healthy lifespan are paramount nowadays.

Indexed as

AgingCaenorhabditis elegansGinsenosidesInsulinInsulin-Like Growth Factor ILipid MetabolismSignal TransductionAnimalsCaenorhabditis elegans ProteinsInsulin-Like PeptidesLongevityPanaxCaenorhabditis elegans Proteinsginsenoside ReGinsenosidesInsulinInsulin-Like Growth Factor IInsulin-Like Peptidesanti-agingCaenorhabditis elegansGinsenoside ReIIS pathwaylipid metabolism

Identifiers

PMID40941989
PMCPMC12430152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.